Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share (OMIC)
CUSIP: 82933R308
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,000
- Total 13F shares
- 709,714
- Share change
- +709,678
- Total reported value
- $5,998,324
- Price per share
- $8.45
- Number of holders
- 22
- Value change
- +$5,998,020
- Number of buys
- 21
Quarterly Holders Quick Answers
What is CUSIP 82933R308?
CUSIP 82933R308 identifies OMIC - Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2024
Recent filing periods for CUSIP 82933R308:
Top shareholders of OMIC - Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| James E. Flynn |
3/4/5
|
*Possible Member of 10% Group, 10%+ Owner |
—
mixed-class rows
|
9,142,019
mixed-class rows
|
$3,891,028 | — | 01 Jun 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
197%
|
4,984,871
|
$2,563,221 | — | 31 Mar 2024 | |
| ARCH Venture Management, LLC |
13F
|
Company |
150%
|
3,798,926
|
$1,953,408 | — | 31 Mar 2024 | |
| QVIDTVM Management LLC |
13F
|
Company |
99%
|
2,506,695
|
$1,288,943 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
87%
|
2,209,383
|
$1,135,623 | — | 31 Mar 2024 | |
| Alexandria Venture Investments, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,645,985
|
$1,120,310 | — | 01 Jun 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
84%
|
2,126,893
|
$1,093,648 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
84%
|
2,119,635
|
$1,089,916 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
74%
|
1,872,582
|
$962,882 | — | 31 Mar 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
52%
|
1,323,885
|
$680,742 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
29%
|
738,711
|
$379,845 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
21%
|
540,697
|
$278,026 | — | 31 Mar 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
21%
|
528,324
|
$272,000 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
20%
|
500,000
|
$257,100 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
18%
|
460,639
|
$236,939 | — | 31 Mar 2024 | |
| Tikvah Management LLC |
13F
|
Company |
13%
|
316,854
|
$162,926 | — | 31 Mar 2024 | |
| Jorge Velarde |
3/4/5
|
Senior Vice President |
—
class O/S missing
|
340,000
|
$143,956 | — | 26 May 2021 | |
| Sam Ropp |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
167,000
mixed-class rows
|
$138,368 | — | 15 Mar 2024 | |
| Triatomic Management LP |
13F
|
Company |
7.7%
|
194,731
|
$100,131 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
6.9%
|
176,000
|
$90,499 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.8%
|
121,500
|
$62,475 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
4.6%
|
116,920
|
$60,120 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.4%
|
112,615
|
$57,907 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4.4%
|
111,200
|
$57,000 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
4%
|
101,851
|
$52,372 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.2%
|
80,363
|
$41,323 | — | 31 Mar 2024 | |
| Weil Company, Inc. |
13F
|
Company |
2.7%
|
68,202
|
$35,069 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
2%
|
51,125
|
$26,288 | — | 31 Mar 2024 | |
| MARINO, STRAM & ASSOCIATES LLC |
13F
|
Company |
1.6%
|
40,000
|
$20,568 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.5%
|
38,815
|
$19,990 | — | 31 Mar 2024 | |
| Vincent Brancaccio |
3/4/5
|
Vice President, HR |
—
class O/S missing
|
32,500
|
$13,761 | — | 26 May 2021 | |
| DLK Investment Management, LLC |
13F
|
Company |
0.99%
|
25,000
|
$12,855 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.97%
|
24,573
|
$12,635 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.85%
|
21,572
|
$11,092 | — | 31 Mar 2024 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.59%
|
15,041
|
$7,734 | — | 31 Mar 2024 | |
| Palumbo Wealth Management LLC |
13F
|
Company |
0.5%
|
12,549
|
$6,453 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.48%
|
12,284
|
$6,316 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.42%
|
10,672
|
$5,485 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.34%
|
8,712
|
$4,480 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.23%
|
5,955
|
$3,061 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.08%
|
2,000
|
$1,000 | — | 31 Mar 2024 | |
| Dynamic Wealth Strategies, LLC |
13F
|
Company |
0.07%
|
1,700
|
$1,000 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
1,662
|
$854 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.03%
|
682
|
$351 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
384
|
$197 | — | 31 Mar 2024 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0.01%
|
172
|
$88 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
29
|
$15 | — | 31 Mar 2024 |
Institutional Holders of Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share (OMIC) as of Q2 2024
As of 30 Jun 2024,
Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share (OMIC) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
709,714 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ARCH Venture Management, LLC, QVIDTVM Management LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, VANGUARD GROUP INC, Casdin Capital, LLC, BlackRock Inc., ORBIMED ADVISORS LLC, and HighTower Advisors, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2024 holders
22
Holder diff
21
| Investor | Q3 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.